Adverse drug reactions: treatment burdens and nurse-led medication monitoring
Article first published online: 1 MAR 2011
© 2011 The Authors. Journal compilation © 2011 Blackwell Publishing Ltd
Journal of Nursing Management
Special Issue: This issue: Adverse events: expecting too much of nurses and too little of nursing research Issue editor: Sue Jordan
Volume 19, Issue 3, pages 377–392, April 2011
How to Cite
GABE, M. E., DAVIES, G. A., MURPHY, F., DAVIES, M., JOHNSTONE, L. and JORDAN, S. (2011), Adverse drug reactions: treatment burdens and nurse-led medication monitoring. Journal of Nursing Management, 19: 377–392. doi: 10.1111/j.1365-2834.2011.01204.x
- Issue published online: 20 APR 2011
- Article first published online: 1 MAR 2011
- Accepted for publication: 12 October 2010
- adverse drug reactions;
- adverse events;
- nurse-led medication monitoring;
- patient safety;
Gabe M.E., Davies G.A., Murphy F., Davies M., Johnstone L. & Jordan S. (2011) Journal of Nursing Management 19, 377–392 Adverse drug reactions: treatment burdens and nurse-led medication monitoring
Aim This paper focuses on adverse drug reactions and the potential for introduction of nurse-led medication monitoring.
Background The prevention of patient harm caused by health-care organizations was accorded international priority over a decade ago, yet adverse drug reactions remain a significant treatment burden to patients.
Evaluation This paper reviews the literature to summarize existing knowledge and understand treatment burdens associated with adverse drug reactions.
Key issues While epidemiological studies explore the magnitude and complex nature of adverse incidents in health-care organizations, the monitoring of prescribed medications and their adverse effects remains an area of concern. Nurse-led medication monitoring has been highlighted as an initiative to minimize unnecessary drug-related patient harm.
Conclusion This paper indicates that nurses are well-placed to monitor and reduce drug-related morbidity, and builds upon previous work which prioritizes the monitoring of prescribed medicine in a nurse-led adverse drug reaction profile.
Implications for nursing management Nurse-led medication monitoring presents a unique opportunity to curtail unnecessary treatment burdens. However, important considerations including, patients’ and professionals’ time, added paperwork, nurse education and training and inter-professional communication need to be explored. Further work is now needed to establish the clinical gains and patient outcomes of nurse-led medication monitoring.